Evaluation of Anti-Tumor Necrosis Factor Levels and Anti-Tumor Necrosis Factor Antibodies in Rheumatic Diseases Treated with Infliximab and Adalimumab; Preliminary Results From a Local Registry

Autores UPV
Año
CONGRESO Evaluation of Anti-Tumor Necrosis Factor Levels and Anti-Tumor Necrosis Factor Antibodies in Rheumatic Diseases Treated with Infliximab and Adalimumab; Preliminary Results From a Local Registry